Finpecia
Prescription
5-Alpha Reductase Inhibitor
Finasteride Tablets
Manufacturer: Cipla
Description
Finpecia is Cipla's branded finasteride 1mg tablet — a type II 5-alpha reductase inhibitor that reduces conversion of testosterone to dihydrotestosterone (DHT). FDA-approved for male androgenetic alopecia. Widely prescribed by Indian dermatologists for male pattern hair loss.
Active Compounds
No tracked compounds
Indications
- Male androgenetic alopecia
- Male pattern baldness
Dosage
1mg once daily. Minimum 3–6 months for visible effect. Continue indefinitely — hair loss resumes on stopping.
Formulations
Full Ingredient List
- Finasteride
- Lactose Monohydrate
- Microcrystalline Cellulose
- Pregelatinised Starch
- Sodium Starch Glycolate
- Docusate Sodium
- Magnesium Stearate
- Hypromellose
- Talc
- Titanium Dioxide
- Iron Oxide Yellow
Side Effects
- Decreased libido (1–2%)
- Erectile dysfunction (1–2%)
- Decreased ejaculate volume
- Gynecomastia (rare)
- Post-finasteride syndrome (controversial)
Warnings
- For men only — absolutely contraindicated in women
- Women of childbearing age must not handle crushed tablets (teratogenic)
- Sexual side effects may persist in rare cases after stopping
- Lowers PSA — inform urologist
- Results take 3–6 months; full effect at 1–2 years